Explore 3 Stock Ideas & Industry Insights Download Free Report

BioSig Technologies, Inc. Common Stock

Company price
6.21 USD -0.06 ( 0.96%)
Last update at 2025-09-17T13:30:00Z
VOLUME
988400
Market Cap
18.96M

Momentum Score

…

BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
5.71
Low
6.52
High
52 Week Price Range
0.20
Low
5.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
6.27
Dividend Yield
-
Revenue TTM
0.04M
Revenue Per Share
0.00
Gross Profit TTM
0.24M
Debt / Equity
-0.16
ROE
-6342.03%
Net Debt
0.26M
ROCE
979.35%
Diluted EPS TTM
-1.34

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -27.26M -32.86M -59.14M -34.47M -17.25M
Minority interest 0.21M 0.94M 0.80M 0.52M 0.52M
Net income -27.27M -31.36M -52.17M -33.92M -17.25M
Selling general administrative 21.38M 27.85M 40.95M 24.81M 12.88M
Gross profit 0.23M 0.24M - - 0.00M
Reconciled depreciation 0.29M 0.20M 0.55M 0.05M 0.01M
Ebit -27.27M -33.41M -59.18M -34.60M -17.26M
Ebitda -26.97M -33.77M -58.63M -34.55M -17.25M
Depreciation and amortization 0.29M -0.35M 0.55M 0.05M 0.01M
Non operating income net other - - -0.00M 0.00M -
Operating income -27.27M -33.41M -59.18M -34.60M -17.26M
Other operating expenses 27.55M 33.85M 59.18M 34.60M 17.26M
Interest expense -0.00M 0.00M 0.04M 0.13M 0.01M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.00M 0.00M 0.04M 0.13M 0.01M
Net interest income 0.00M 0.00M 0.04M 0.13M 0.01M
Extraordinary items - - - - 3.20M
Income tax expense 0.01M -1.49M -6.97M -0.55M 0.02M
Total revenue 0.29M 0.44M 0.00M 0.00M 0.00M
Total operating expenses 27.49M 33.65M 59.18M 34.60M 17.26M
Cost of revenue 0.06M 0.20M - - 0.00M
Total other income expense net 0.00M 0.56M 0.04M 0.13M 0.01M
Net income from continuing ops -27.26M -32.86M -59.14M -34.47M -17.25M
Net income applicable to common shares - -31.93M -52.23M -34.08M -18.14M
Preferred stock and other adjustments - - 0.01M 0.03M 0.88M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 1.80M 4.11M 15.52M 30.39M 14.22M
Intangible assets 0.29M 0.31M 0.33M 0.35M 0.37M
Other current assets 0.31M 0.00M 0.35M 0.30M 0.14M
Total liab 4.68M 3.71M 2.95M 5.11M 2.34M
Total stockholder equity -2.91M 0.42M 12.35M 24.48M 11.36M
Other current liab 4.22M 2.94M 2.26M 4.79M 1.62M
Common stock 0.01M 0.06M 0.04M 0.03M 0.02M
Capital stock 0.11M 0.16M 0.14M 0.14M 0.24M
Retained earnings -245.01M -215.97M -188.92M -157.00M -104.79M
Other liab - - 0.01M - -
Other assets - - 0.04M -0.00M 0.13M
Cash 0.19M 0.36M 11.66M 28.27M 12.11M
Total current liabilities 4.58M 3.26M 2.58M 5.11M 2.03M
Current deferred revenue 0.02M 0.01M 0.03M - -
Net debt 0.26M 0.41M -11.00M -27.95M -11.39M
Short term debt 0.35M 0.31M 0.28M 0.31M 0.41M
Short long term debt total 0.45M 0.77M 0.66M 0.31M 0.72M
Other stockholder equity 242.09M 216.23M 201.13M 181.34M 115.91M
Property plant equipment - - 1.26M 0.59M 0.89M
Total current assets 0.53M 1.13M 13.89M 29.34M 12.83M
Net tangible assets - - 11.91M 24.02M 10.78M
Short term investments 0.10M 0.10M - - -
Net receivables 0.02M 0.01M - - -
Inventory -0.10M 0.34M 1.88M 0.77M 0.58M
Accounts payable - 0.00M 0.00M 0.03M 0.35M
Noncontrolling interest in consolidated entity - - - 0.80M 0.51M
Accumulated other comprehensive income -0.10M - - - -0.45M
Common stock total equity - - - 0.03M 0.02M
Retained earnings total equity - - - -157.00M -104.79M
Non currrent assets other 0.04M 1.18M 0.04M 0.11M 0.13M
Non current assets total 1.27M 2.98M 1.62M 1.05M 1.39M
Capital lease obligations 0.45M 0.77M 0.66M 0.31M 0.72M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.17M -0.54M -0.09M -0.29M -0.31M
Change to liabilities - -1.95M 3.23M 0.54M 0.48M
Total cashflows from investing activities - -0.54M -0.09M -0.29M -0.31M
Total cash from financing activities 10.57M 10.33M 42.85M 23.43M 13.47M
Change to operating activities - -0.39M -0.59M -0.03M -0.10M
Net income -27.26M -32.86M -59.14M -34.47M -17.25M
Change in cash -11.30M -16.61M 16.16M 7.66M 2.90M
Begin period cash flow 11.66M 28.27M 12.11M 4.45M 1.55M
End period cash flow 0.36M 11.66M 28.27M 12.11M 4.45M
Total cash from operating activities -21.70M -26.40M -26.60M -15.48M -10.26M
Issuance of capital stock 10.35M 10.30M 27.44M 10.01M 10.63M
Depreciation 0.29M 0.20M 0.55M 0.05M 0.01M
Other cashflows from investing activities - - - -0.11M -0.27M
Dividends paid -0.00M -0.01M -0.18M -0.40M 0.74M
Change to inventory 0.28M -1.11M -0.29M -0.58M -0.58M
Change to account receivables -0.01M 1.99M -3.23M -0.54M -
Sale purchase of stock - - 42.85M 23.43M 13.47M
Other cashflows from financing activities 0.22M 0.04M 15.58M 13.82M 5.07M
Change to netincome - 8.33M 22.72M 19.01M 6.60M
Capital expenditures 0.17M 0.54M 0.09M 0.29M 0.31M
Cash flows other operating - - -0.14M -0.04M -0.10M
Cash and cash equivalents changes - - 16.16M 7.66M 2.90M
Change in working capital 0.46M -3.45M 2.35M -0.07M 0.38M
Stock based compensation 4.41M 9.50M 25.16M 15.18M 6.60M
Other non cash items 0.39M 0.44M 4.47M 3.83M -5.35M
Free cash flow -21.87M -26.94M -26.69M -15.77M -10.56M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BSGM
BioSig Technologies, Inc. Common Stock
-0.06
0.96%
6.21 - - 473.96 36.58 617.17 -2.34
ABT
Abbott Laboratories
-0.71
0.65%
108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
0.28
0.28%
101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-2.16
0.68%
316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-
-%
47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

BioSig Technologies, Inc. Common Stock

BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

55 Greens Farms Road, Westport, CT, United States, 06880

203 409 5444

4

Name Title Year Born
Mr. Kenneth L. Londoner M.B.A., MBA Founder, CEO & Exec. Chairman 1968
Mr. Steven Chaussy CPA Chief Financial Officer 1954
Mr. John Sieckhaus Chief Operating Officer 1968
Dr. Budimir S. Drakulic Ph.D. Chief Scientist 1950
Mr. Andrew Gornell Ballou VP of Investor Relations NA
Ms. Brenda Castrodad VP of HR NA
Mr. Gray Fleming Jr. Chief Commercial Officer NA
Mr. Frederick D. Hrkac President, Principal Executive Officer & Executive VP 1967
Mr. Andrew Gornell Ballou Vice President of Investor Relations NA
Mr. Frederick D. Hrkac President, Principal Executive Officer, Executive VP & Director 1966

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…